| 摘要: |
| 恶性肿瘤是严重威胁人类健康的疾病,手术切除仍是早期肿瘤的首选根治性治疗手段,而切除手术中示踪剂通过实时可视化肿瘤组织,可使肿瘤全切率提升,术后复发率降低,成为精准外科的核心技术支撑。本文对已上市及在研的典型术中示踪剂进行了综述,为更多术中示踪剂的研发提供依据。 |
| 关键词: 癌症 恶性肿瘤 术中示踪剂 作用机制 |
| DOI:10.13506/j.cnki.jpr.2026.06.012 |
| 基金项目: |
|
Received Date:April 11, 2026
Revision Date:June 12, 2026
|
|
| Research progress on intraoperative tracers for tumor surgery |
| LI Zongtao,YANG Xueqian,GE Yongxi,ZHANG Jianyong |
| (Shandong Qidu Pharmaceutical Co.,Ltd, Zibo 255000, China) |
| Abstract: |
| Malignant tumors represent a severe threat to human health, and surgical resection remains the first-line curative treatment of choice for early-stage malignancies. During resection procedures, intraoperative tracers enable real-time visualization of tumor tissue, which can improve the gross total resection (GTR) rate and reduce postoperative recurrence rates, establishing them as a core technical pillar of precision surgery. This review comprehensively summarizes representative commercially available and investigational intraoperative tracers, providing a solid foundation for the research and development of more such agents. |
| Key words: Cancer Malignant tumors Intraoperative Tracers Mechanism of action |